Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Please share Science & Enterprise

Infographic – Univ. Leadership Still a Man’s World

Chart: Women in university leadership

While women now make up a majority of Ph.D. degrees in the U.S., the people leading most of America’s research universities continue to be men. . . . → Read More: Infographic – Univ. Leadership Still a Man’s World

Hydrogel Shown to Boost Beneficial Gut Microbes

Gut microbes

Tests with lab mice show a highly absorbent biocompatible gel promotes the growth of beneficial microbes associated with good metabolic health. . . . → Read More: Hydrogel Shown to Boost Beneficial Gut Microbes

Semiconductor Tech Drug Discovery Company Underway

Neurons on electrodes

A drug discovery company with an electronic screening process based on semiconductor technology is starting up and raising $9.25 million in seed funds. . . . → Read More: Semiconductor Tech Drug Discovery Company Underway

Trial Begins for Skin-Implanted Addiction Therapy

Ambulance at night

A clinical trial is underway testing a therapy for opioid use disorder that places a treatment drug pellet under the skin lasting for 12 weeks. . . . → Read More: Trial Begins for Skin-Implanted Addiction Therapy

State Grant Funds Virus-Immunotherapy Cancer Trial

T-cells and cancer cells

A California state agency is helping fund a clinical trial testing an immunotherapy combined with a cancer-killing virus to treat solid tumor cancers. . . . → Read More: State Grant Funds Virus-Immunotherapy Cancer Trial

Early Trials Show Responses for Some Blood Cancers

Natural killer cell

First results from two clinical trials testing the safety of natural killer cell therapies show responses by patients with some forms of blood-related cancers. . . . → Read More: Early Trials Show Responses for Some Blood Cancers

How To Be Different in Business

Customers first must discover you, notice you, and want to buy from you before they know that you’re an excellent choice. . . . → Read More: How To Be Different in Business

Infographic – US Biotech Venture Deals Slow in Q1

Chart: Biotech venture deals

The rate of new venture deals for biotechnology start-ups in the U.S. slowed in the first quarter of 2022, but total dollars invested remain on track from last year. . . . → Read More: Infographic – US Biotech Venture Deals Slow in Q1

Ginkgo Acquires Bayer Agricultural Biologics Technology

Iowa cornfield

Synthetic biology developer Ginkgo Bioworks is acquiring agricultural biologics assets from Bayer, transforming the companies’ five-year partnership. . . . → Read More: Ginkgo Acquires Bayer Agricultural Biologics Technology

Post removed

Sponsored post removed for non-payment.

* * *